Literature DB >> 26540659

MicroRNA-184 Regulates Corneal Lymphangiogenesis.

Sammy Grimaldo, Don Yuen, Jaci Theis, Melissa Ng, Tatiana Ecoiffier, Lu Chen.   

Abstract

PURPOSE: MicroRNAs are a class of small noncoding RNAs that negatively regulate gene expression by binding to complimentary sequences of target messenger RNA. Their roles in corneal lymphangiogenesis are largely unknown. This study was to investigate the specific role of microRNA-184 (mir-184) in corneal lymphangiogenesis (LG) in vivo and lymphatic endothelial cells (LECs) in vitro.
METHODS: Standard murine suture placement model was used to study the expressional change of mir-184 in corneal inflammatory LG and the effect of synthetic mir-184 mimic on this process. Additionally, a human LEC culture system was used to assess the effect of mir-184 overexpression on cell functions in vitro.
RESULTS: Expression of mir-184 was significantly downregulated in corneal LG and, accordingly, its synthetic mimic suppressed corneal lymphatic growth in vivo. Furthermore, mir-184 overexpression in LECs inhibited their functions of adhesion, migration, and tube formation in vitro.
CONCLUSIONS: These novel findings indicate that mir-184 is involved critically in LG and potentially could be used as an inhibitor of the process. Further investigation holds the promise for divulging new therapies for LG disorders, which occur inside and outside the eye.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26540659      PMCID: PMC4640472          DOI: 10.1167/iovs.15-17733

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays.

Authors:  Tobias Gebäck; Martin Michael Peter Schulz; Petros Koumoutsakos; Michael Detmar
Journal:  Biotechniques       Date:  2009-04       Impact factor: 1.993

3.  MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity.

Authors:  David G Ryan; Michelle Oliveira-Fernandes; Robert M Lavker
Journal:  Mol Vis       Date:  2006-10-17       Impact factor: 2.367

Review 4.  The promise of microRNA replacement therapy.

Authors:  Andreas G Bader; David Brown; Matthew Winkler
Journal:  Cancer Res       Date:  2010-08-31       Impact factor: 12.701

5.  Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation.

Authors:  Tina Dietrich; Felix Bock; Don Yuen; Deniz Hos; Björn O Bachmann; Grit Zahn; Stanley Wiegand; Lu Chen; Claus Cursiefen
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

6.  MeCP2-dependent repression of an imprinted miR-184 released by depolarization.

Authors:  Tasuku Nomura; Mika Kimura; Takuro Horii; Sumiyo Morita; Hidenobu Soejima; Shinichi Kudo; Izuho Hatada
Journal:  Hum Mol Genet       Date:  2008-01-18       Impact factor: 6.150

7.  Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.

Authors:  Romulo J C Albuquerque; Takahiko Hayashi; Won Gil Cho; Mark E Kleinman; Sami Dridi; Atsunobu Takeda; Judit Z Baffi; Kiyoshi Yamada; Hiroki Kaneko; Martha G Green; Joe Chappell; Jörg Wilting; Herbert A Weich; Satoru Yamagami; Shiro Amano; Nobuhisa Mizuki; Jonathan S Alexander; Martha L Peterson; Rolf A Brekken; Masanori Hirashima; Seema Capoor; Tomohiko Usui; Balamurali K Ambati; Jayakrishna Ambati
Journal:  Nat Med       Date:  2009-08-09       Impact factor: 53.440

8.  MicroRNAs regulate ocular neovascularization.

Authors:  Jikui Shen; Xiaoru Yang; Bing Xie; Yangjian Chen; Mara Swaim; Sean F Hackett; Peter A Campochiaro
Journal:  Mol Ther       Date:  2008-05-20       Impact factor: 11.454

Review 9.  Ocular lymphatics: state-of-the-art review.

Authors:  L Chen
Journal:  Lymphology       Date:  2009-06       Impact factor: 1.286

10.  Identification and characterization of microRNAs expressed in the mouse eye.

Authors:  Marianthi Karali; Ivana Peluso; Valeria Marigo; Sandro Banfi
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

View more
  7 in total

1.  MiR-199a/b-5p Inhibits Lymphangiogenesis by Targeting Discoidin Domain Receptor 1 in Corneal Injury.

Authors:  Sooeun Oh; Minkoo Seo; Jun-Sub Choi; Choun-Ki Joo; Suk Kyeong Lee
Journal:  Mol Cells       Date:  2018-02-02       Impact factor: 5.034

Review 2.  Non-coding RNAs as Regulators of Lymphangiogenesis in Lymphatic Development, Inflammation, and Cancer Metastasis.

Authors:  Ming-Xin Cao; Ya-Ling Tang; Wei-Long Zhang; Ya-Jie Tang; Xin-Hua Liang
Journal:  Front Oncol       Date:  2019-09-20       Impact factor: 6.244

Review 3.  MicroRNAs in Ocular Infection.

Authors:  Shunbin Xu; Linda D Hazlett
Journal:  Microorganisms       Date:  2019-09-17

4.  MicroRNA Profiling of Highly Enriched Human Corneal Epithelial Stem Cells by Small RNA Sequencing.

Authors:  Lavanya Kalaimani; Bharanidharan Devarajan; Umadevi Subramanian; Vanniarajan Ayyasamy; Venkatesh Prajna Namperumalsamy; Muthukkaruppan Veerappan; Gowri Priya Chidambaranathan
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

5.  Tear miRNA expression analysis reveals miR-203 as a potential regulator of corneal epithelial cells.

Authors:  Ayumi Nakagawa; Takeshi Nakajima; Mitsuyoshi Azuma
Journal:  BMC Ophthalmol       Date:  2021-10-25       Impact factor: 2.209

Review 6.  Role of miRNAs in vascular development.

Authors:  Albert Sufianov; Sema Begliarzade; Valentin Kudriashov; Radmila Nafikova; Tatiana Ilyasova; Yanchao Liang
Journal:  Noncoding RNA Res       Date:  2022-09-29

7.  Profilings of MicroRNAs in the Liver of Common Carp (Cyprinus carpio) Infected with Flavobacterium columnare.

Authors:  Lijuan Zhao; Hong Lu; Qinglei Meng; Jinfu Wang; Weimin Wang; Ling Yang; Li Lin
Journal:  Int J Mol Sci       Date:  2016-04-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.